| 08:00 - 10:20 | 40 | EW1 Advanced bronchoscopy | Educational Workshop |
| 08:30 - 10:30 | 41 | Chemicals made to harm: from pepper spray to mustard gas and from molecular mechanisms to human rights | Grand round |
| 08:30 - 10:30 | 42 | Severe lung hyperinflation: troubles and solutions | Symposium |
| 08:30 - 10:30 | 44 | Two are better than one? Endorsement of noninvasive ventilation (NIV) | Symposium |
| 08:30 - 10:30 | 45 | From respiratory infections to wheezing: reevaluating the role of vitamin D levels in childhood | Symposium |
| 08:30 - 10:30 | 46 | The merits of exercise in patients with non-small cell lung cancer (NSCLC) | Symposium |
| 08:30 - 10:30 | 47 | New aspects of lung function testing in children | Oral Presentation |
| 08:30 - 10:30 | 48 | Novel epigenetic regulators for targeting via nanomedicine | Oral Presentation |
| 08:30 - 10:30 | 49 | How quality of care impacts cost effectiveness | Oral Presentation |
| 08:30 - 10:30 | 50 | Monitoring COPD with different biomarkers | Oral Presentation |
| 08:30 - 10:30 | 51 | The impact of the Global Lung Initiative (GLI) reference equations and spirometry quality in all ages | Oral Presentation |
| 08:30 - 10:30 | 52 | Asthma: still a heterogeneous condition! | Oral Presentation |
| 08:30 - 10:30 | 53 | Three ages of man: OSA in children, adults and the elderly | Oral Presentation |
| 08:30 - 10:30 | 54 | Interventions and other therapeutic approaches in respiratory infections | Poster Discussion |
| 08:30 - 10:30 | 55 | Maximise lung transplant outcomes: pre- and post-operative issues | Poster Discussion |
| 08:30 - 10:30 | 56 | Lung disease in neonates and beyond | Oral Presentation |
| 08:30 - 10:30 | 57 | Clinical trials of drugs and biomarkers for respiratory diseases | Poster Discussion |
| 08:30 - 10:30 | 58 | Pulmonary hypertension: pathobiology | Poster Discussion |
| 08:30 - 10:30 | 59 | Three smoking-related diseases: cardiovascular, lung cancer and infection | Poster Discussion |
| 08:30 - 10:30 | 60 | Improving diagnosis of thoracic tumours | Poster Discussion |
| 10:40 - 13:00 | 62 | EW2 Advanced bronchoscopy | Educational Workshop |
| 10:45 - 12:45 | 63 | Sadoul Lecture “From molecules and cells to phenotypes: deciphering chronic airways disease” followed by related presentations | Sadoul Lecture |
| 10:45 - 13:15 | 64 | ERS/WHO joint Hot Topic "Tuberculosis (TB), tobacco and mobile phones" followed by the official launch of the ERS/WHO framework on TB elimination | Hot topics |
| 10:45 - 12:45 | 65 | Diagnosis of paediatric obstructive sleep apnoea (OSA) in settings with limited resources | Hot topics |
| 10:45 - 12:45 | 67 | Multitasking: mental coach qualities of the respiratory health professional | Symposium |
| 10:45 - 12:45 | 68 | Mesothelioma: a never-ending story | Symposium |
| 10:45 - 12:45 | 69 | Virus-triggered lower respiratory disease in children | Oral Presentation |
| 10:45 - 12:45 | 70 | Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer | Oral Presentation |
| 10:45 - 12:45 | 71 | Occupational asthma: from childhood to adulthood | Oral Presentation |
| 10:45 - 12:45 | 72 | Best abstracts in rehabilitation and chronic care (sponsored by MOTEK Medical) | Oral Presentation |
| 10:45 - 12:45 | 73 | New insights into the epidemiology of COPD | Oral Presentation |
| 10:45 - 12:45 | 74 | Paediatric asthma: what is new for the clinician? | Oral Presentation |
| 10:45 - 12:45 | 75 | Determinants of asthma and lung function in childhood | Oral Presentation |
| 10:45 - 12:45 | 76 | Home noninvasive ventilation: still a "work in progress"? | Poster Discussion |
| 10:45 - 12:45 | 77 | Sarcoidosis | Poster Discussion |
| 10:45 - 12:45 | 78 | Immunology of respiratory infections | Oral Presentation |
| 10:45 - 12:45 | 79 | The planet of the pleura | Poster Discussion |
| 10:45 - 12:45 | 80 | Pathology and prognostic factors of thoracic tumours | Poster Discussion |
| 10:45 - 12:45 | 81 | COPD exacerbations | Poster Discussion |
| 10:45 - 12:45 | 82 | Functional imaging | Poster Discussion |
| 12:50 - 14:40 | 84 | Markers | Thematic Poster Session |
| 12:50 - 14:40 | 85 | Clinical management of lung diseases: from bronchi to pleura | Thematic Poster Session |
| 12:50 - 14:40 | 86 | Best posters in pulmonary rehabilitation 1 | Thematic Poster Session |
| 12:50 - 14:40 | 87 | Best posters in pulmonary rehabilitation 2 | Thematic Poster Session |
| 12:50 - 14:40 | 88 | COPD and PAH related imaging | Thematic Poster Session |
| 12:50 - 14:40 | 89 | Different modalities and techniques for lung imaging | Thematic Poster Session |
| 12:50 - 14:40 | 90 | Bronchoscopy in peripheral pulmonary lesions and diffuse lung diseases | Thematic Poster Session |
| 12:50 - 14:40 | 91 | Diagnostic and therapeutic bronchoscopy: old and new techniques for interventional pulmonology | Thematic Poster Session |
| 12:50 - 14:40 | 92 | ILDs: connective tissue disease | Thematic Poster Session |
| 12:50 - 14:40 | 93 | ILDs 1 | Thematic Poster Session |
| 12:50 - 14:40 | 94 | ILDs 2 | Thematic Poster Session |
| 12:50 - 14:40 | 95 | ILDs 3 | Thematic Poster Session |
| 12:50 - 14:40 | 96 | Diagnosis and treatment of COPD in primary care | Thematic Poster Session |
| 12:50 - 14:40 | 97 | Basic and translational research in lung cancer and non-neoplastic pulmonary diseases | Thematic Poster Session |
| 12:50 - 14:40 | 98 | Translational studies in COPD | Thematic Poster Session |
| 12:50 - 14:40 | 99 | Animal models: asthma, COPD and beyond | Thematic Poster Session |
| 12:50 - 14:40 | 100 | Lung cell biology in injury and repair | Thematic Poster Session |
| 12:50 - 14:40 | 101 | Asthma and COPD management | Thematic Poster Session |
| 12:50 - 14:40 | 102 | Asthma and COPD devices and treatments | Thematic Poster Session |
| 12:50 - 14:40 | 103 | Rationale behind respiratory drug development | Thematic Poster Session |
| 12:50 - 14:40 | 104 | Novel evidence relating to respiratory treatment development | Thematic Poster Session |
| 12:50 - 14:40 | 105 | The assessment of comorbidities | Thematic Poster Session |
| 12:50 - 14:40 | 106 | Airway biomarkers | Thematic Poster Session |
| 12:50 - 14:40 | 107 | Mechanistic murine studies of asthma and lung inflammation | Thematic Poster Session |
| 12:50 - 14:40 | 108 | Biomarkers of asthma and clinical immunology | Thematic Poster Session |
| 12:50 - 14:40 | 109 | The epidemiology of respiratory infections and lung cancer | Thematic Poster Session |
| 12:50 - 14:40 | 110 | Prevalence of COPD and mortality from COPD | Thematic Poster Session |
| 12:50 - 14:40 | 111 | Environment and mechanisms | Thematic Poster Session |
| 12:50 - 14:40 | 112 | Occupational respiratory diseases: from drug-induced disease to COPD induced by the uranium industry | Thematic Poster Session |
| 12:50 - 14:40 | 113 | Smoking in teenagers and shisha, beedis and cannabis' use in all ages | Thematic Poster Session |
| 12:50 - 14:40 | 114 | Respiratory physiology and sleep disordered breathing in children | Thematic Poster Session |
| 12:50 - 14:40 | 115 | Paediatric asthma: pharmacological and non-pharmacological management | Thematic Poster Session |
| 12:50 - 14:40 | 116 | Paediatric asthma: epidemiology and risk factors | Thematic Poster Session |
| 12:50 - 14:40 | 117 | Cystic fibrosis: genotypes, inflammation and microbiology | Thematic Poster Session |
| 12:50 - 14:40 | 118 | Cystic fibrosis: clinical assessment and treatment | Thematic Poster Session |
| 12:50 - 14:40 | 119 | Respiratory infections in children | Thematic Poster Session |
| 12:50 - 14:40 | 120 | Paediatric epidemiology: new insights into primary ciliary dyskinesia, prematurity and bronchiolitis | Thematic Poster Session |
| 12:50 - 14:40 | 121 | Respiratory function at rest and during exercise | Thematic Poster Session |
| 12:50 - 14:40 | 122 | Physical activity, exercise and physiotherapy in patients with COPD | Thematic Poster Session |
| 12:50 - 14:40 | 123 | From individual patient interactions to models of care: the nursing perspective | Thematic Poster Session |
| 13:00 - 14:30 | 124 | ERS/JAMA lunchtime session: 2014 highlights | Symposium |
| 13:00 - 14:30 | 125 | How best to prepare for your conference contribution? | Symposium |
| 13:00 - 14:30 | 127 | Clinical utility of multiple breath washout (MBW): why is assessing ventilation inhomogeneity important? | Symposium |
| 13:00 - 14:00 | 132 | ME01 Endoscopic lung volume reduction (ELVR) | Meet the expert |
| 13:00 - 14:00 | 133 | ME02 See me, feel me, touch me, heal me - different patterns of pulmonary adenocarcinomas in the new IASLC/ATS/ERS classification | Meet the expert |
| 13:00 - 14:00 | 134 | ME03 Management of tracheal and major airway problems | Meet the expert |
| 13:00 - 14:00 | 135 | ME04 Fungal respiratory infection | Meet the expert |
| 13:15 - 14:30 | 137 | Comorbidities in sleep disordered breathing - clinical consequences and therapeutic solution | Practical Workshop |
| 13:15 - 14:30 | 138 | Practical approaches on how to maximise compliance and optimise quality of care with telemonitoring, innovative therapy technology and therapy alternatives | Practical Workshop |
| 13:15 - 14:30 | 140 | Ambulatory oxygen in clinical practice | Practical Workshop |
| 14:30 - 16:50 | 142 | EW3 Advanced bronchoscopy | Educational Workshop |
| 14:45 - 16:45 | 143 | Paediatric grand round - an interactive session | Grand round |
| 14:45 - 16:45 | 144 | Is asthma prevalence still increasing? | Symposium |
| 14:45 - 16:45 | 145 | The evolving role of real-life research in respiratory medicine | Symposium |
| 14:45 - 16:45 | 146 | Current therapeutic options in stage I non-small cell lung cancer (NSCLC) | Symposium |
| 14:45 - 16:45 | 147 | Ceremony for the ERS COPD research Award 2014 - Symposium: Finding patients with COPD: how, when and where | Symposium |
| 14:45 - 16:45 | 148 | Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases" | Symposium |
| 14:45 - 16:45 | 149 | What is emerging from ERS Task Forces in terms of outcome measures for adult respiratory disease | Symposium |
| 14:45 - 16:45 | 150 | Critical illness and therapeutic interventions | Oral Presentation |
| 14:45 - 16:45 | 151 | Mechanisms of exercise limitation in disease | Oral Presentation |
| 14:45 - 16:45 | 152 | Smoking and respiratory airway function and diseases | Oral Presentation |
| 14:45 - 16:45 | 153 | Qualitative and quantitative research that contributes to respiratory nursing practice | Oral Presentation |
| 14:45 - 16:45 | 154 | Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells | Oral Presentation |
| 14:45 - 16:45 | 155 | Chronic lung allograft dysfunction: mechanisms, predictors and phenotypes | Oral Presentation |
| 14:45 - 16:45 | 156 | Tuberculosis: epidemiology and public health | Poster Discussion |
| 14:45 - 16:45 | 157 | Management of COPD in primary care | Poster Discussion |
| 14:45 - 16:45 | 158 | New insights into monocyte and macrophage biology | Poster Discussion |
| 14:45 - 16:45 | 159 | Exposure measurement and biological effects of pollutants at work, outdoor and at home | Poster Discussion |
| 14:45 - 16:45 | 160 | New treatments for cough, asthma, COPD and ILDs | Poster Discussion |
| 14:45 - 16:45 | 161 | Of mice and men: physiology and biology of sleep disordered breathing | Poster Discussion |